glp 1 and ckd Design discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis SGLT2 vs GLP-1 for CKD:

With its anti-inflammatory properties , it helps the body fight off external pathogens

And 90 percent of the time Im really good at it because a protein diet is good for me anyway

In milder cases of non-diabetic hyperglycaemia, patients can use our toolkit to address these issues without the need for GLP-1 mimetic therapy with the option to escalate to a pharmacologically assisted Metabolic Reset, only if needed

GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise